Optogenetics & Precision Medicine Debate at SERV Congress
- Santiago de Compostela, March 10, 2025 – The XXVIII edition of the Sociedad Española de Retina y Vítreo (SERV) congress concluded, gathering over 1,200 ophthalmology professionals in Santiago...
- Optogenetics, an innovative technique still in clinical trials, emerged as a prominent topic.
- The congress also addressed personalized precision medicine, focusing on how image analysis and artificial intelligence can tailor treatments to individual patients.
Innovations in Retina and Vitreous Disease Treatment Highlighted at SERV Congress
Table of Contents
- Innovations in Retina and Vitreous Disease Treatment Highlighted at SERV Congress
- Innovations in Retina and Vitreous Disease Treatment: Key Insights from the SERV Congress
- What were the main topics discussed at the SERV Congress?
- What is optogenetics, and how is it being used in vision treatment?
- How is personalized medicine being applied in ophthalmology?
- What are the benefits of new intravitreal therapies discussed at the SERV Congress?
- What is the controversy surrounding the use of artificial intelligence in ophthalmology?
- What are the limitations of AI in ophthalmology?
- What is the ‘myopia pandemic,’ and what measures are being taken to combat it?
- What preventative measures are being proposed to combat Myopia?
- What other chronic conditions were identified as major challenges at the congress?
- Who is Professor José Pulido, and why did he receive the SERV Medal of Honor?
- Summary of Key Advancements and Challenges Discussed at the SERV Congress
Santiago de Compostela, March 10, 2025 – The XXVIII edition of the Sociedad Española de Retina y Vítreo (SERV) congress concluded, gathering over 1,200 ophthalmology professionals in Santiago de Compostela. The congress focused on exchanging knowledge and exploring the latest advancements in treating diseases of the retina, choroid, and vitreous.
Key Highlights from the SERV Congress
- Debates centered on optogenetics, personalized precision medicine, and novel intravitreal therapies.
- The role of artificial intelligence in ophthalmology sparked considerable discussion.
- Emphasis placed on preventing the growing ‘myopia pandemic’.
- Professor José Pulido received the SERV Medal of Honor for his research contributions.
Optogenetics: A Promising Technique
Optogenetics, an innovative technique still in clinical trials, emerged as a prominent topic. According to SERV President Professor Alfredo García Layana, initial results “permiten a gente que no ve, recuperar parcialmente la visión” (“allow people who cannot see to partially recover thier vision”). This method involves converting certain retinal cells into light transmitters.
Personalized Medicine and Artificial Intelligence
The congress also addressed personalized precision medicine, focusing on how image analysis and artificial intelligence can tailor treatments to individual patients. the introduction of new intravitreal therapies offers significant benefits. García Layana noted that these therapies ”permiten reducir la carga asistencial, es decir, conseguir los mismos resultados con menos inyecciones intermedias, lo cual es un alivio para el sistema sanitario” (“reduce the care burden, that is, achieve the same results with fewer intermediate injections, which is a relief for the healthcare system”).
The “Controversy” Surrounding Artificial Intelligence
While artificial intelligence is increasingly used in ophthalmology for image analysis, interpretation, and algorithm creation, its implementation faces challenges.The SERV president acknowledged that it remains a “muy controvertido” (“very controversial”) topic.
He further elaborated, “A día de hoy todos tenemos claro que la inteligencia artificial va a suponer un avance y una herramienta en el día a día de nuestra práctica clínica, pero también hay muchos puntos que tienen que ser todavía aclarados” (“Today, we are all clear that artificial intelligence will be an advance and a tool in the daily practice of our clinical practice, but there are also many points that have yet to be clarified”). Ethical, legal, and data protection limitations require careful consideration: “¿Quién asume la responsabilidad de la toma de decisiones?” (“Who assumes duty for decision-making?”).
Combating the Myopia Pandemic Through Prevention
The Sociedad Española de Retina y Vítreo identifies the rising prevalence of chronic conditions, such as age-related macular degeneration, diabetic retinopathy, and the ‘myopia pandemic,’ as major challenges. Dr. Luis Arias Barquet, Vice President of SERV, emphasized the need to “insistir en la prevención y trabajar codo con codo con autoridades sanitarias y con otras especialidades o subespecialidades de la oftalmología” (“insist on prevention and work side by side with health authorities and other specialties or subspecialties of ophthalmology”) to curb this pathology, as “la miopía y la alta miopía van a ser la principal causa de discapacidad visual en nuestro país durante el siglo XXI” (“myopia and high myopia will be the main cause of visual impairment in our country during the 21st century”).
Innovations in Retina and Vitreous Disease Treatment: Key Insights from the SERV Congress
Here are the key takeaways from the XXVIII edition of the Sociedad Española de Retina y Vítreo (SERV) congress held in Santiago de Compostela on March 10, 2025.
What were the main topics discussed at the SERV Congress?
The SERV Congress, which gathered more than 1,200 ophthalmology professionals, primarily focused on cutting-edge advancements in the treatment of retinal, choroidal, and vitreous diseases. Key topics included:
Optogenetics
Personalized precision medicine
Novel intravitreal therapies
The role of artificial intelligence (AI) in ophthalmology
Prevention of the ‘myopia pandemic’
What is optogenetics, and how is it being used in vision treatment?
Optogenetics is an innovative technique currently in clinical trials that aims to restore partial vision in individuals who are blind. According to SERV President Professor Alfredo García Layana, early results are promising. The technique involves converting certain retinal cells into light transmitters, effectively bypassing damaged photoreceptors.
How is personalized medicine being applied in ophthalmology?
Personalized precision medicine, leveraging image analysis and artificial intelligence, is being used to tailor treatments to individual patients. This approach aims to optimize treatment outcomes by considering the unique characteristics of each patient’s condition.
What are the benefits of new intravitreal therapies discussed at the SERV Congress?
Professor García Layana highlighted that new intravitreal therapies can “reduce the care burden” by achieving the same results with fewer injections.This reduces the burden on both patients and the healthcare system.
What is the controversy surrounding the use of artificial intelligence in ophthalmology?
While AI is increasingly used for image analysis,interpretation,and algorithm creation in ophthalmology,it’s implementation faces ethical,legal,and data protection challenges. The SERV president acknowledged AI as “very controversial,” raising questions about responsibility for decision-making when AI systems are involved.
What are the limitations of AI in ophthalmology?
Key limitations and concerns regarding AI in ophthalmology include:
Ethical considerations: Ensuring fairness and avoiding bias in AI algorithms.
legal aspects: Determining liability when AI-driven systems make incorrect diagnoses or treatment recommendations.
data protection: Safeguarding patient data and maintaining privacy.
* Accountability: Defining who is responsible when AI makes errors.
What is the ‘myopia pandemic,’ and what measures are being taken to combat it?
The ‘myopia pandemic’ refers to the increasing prevalence of nearsightedness (myopia) worldwide. Dr. Luis Arias Barquet, Vice President of SERV, stressed the need for prevention and collaboration with health authorities and other ophthalmology subspecialties to address this issue. He emphasized that “myopia and high myopia will be the main cause of visual impairment in our country during the 21st century”.
What preventative measures are being proposed to combat Myopia?
While the specific preventative measures were not provided in the document, the article stated the need to “insist on prevention and work side by side with health authorities and other specialties or subspecialties of ophthalmology” to curb Myopia.
What other chronic conditions were identified as major challenges at the congress?
Besides the ‘myopia pandemic,’ age-related macular degeneration and diabetic retinopathy were also identified as significant challenges by the Sociedad Española de Retina y Vítreo.
Who is Professor José Pulido, and why did he receive the SERV Medal of Honor?
Professor José Pulido received the SERV medal of Honor for his significant research contributions to the field of retina and vitreous diseases. The specific details of his research were not outlined in this article.
Summary of Key Advancements and Challenges Discussed at the SERV Congress
| Topic | Advancement | Challenge/Controversy |
| —————————- | ——————————————————————————————————————————— | —————————————————————————————————————– |
| Optogenetics | Potential to restore partial vision in blind individuals by converting retinal cells into light transmitters. | Still in clinical trials. |
| Personalized Medicine | Tailoring treatments using image analysis and AI for optimized patient outcomes. | Ensuring data privacy and security. |
| Intravitreal Therapies | Reduced care burden due to fewer necessary injections. | |
| Artificial Intelligence | Improved image analysis, interpretation, and algorithm creation. | Ethical, legal, and data protection limitations. Determining responsibility for AI-driven decisions. |
| Prevention of Myopia Pandemic | Emphasis on early prevention and collaboration among healthcare professionals and authorities. | The increasing rise of cases |